← Back to Search

Procedure

PEAL surgery for Urological Diseases

N/A
Waitlist Available
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients undergoing laparoscopic urologic surgery
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 days postoperatively
Awards & highlights

Study Summary

This trial will study a new type of minimally-invasive surgery that uses small instruments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 days postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 30 days postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain score of all surgical sites
Time to first opioid use
Total inpatient opioid dosage

Trial Design

1Treatment groups
Experimental Treatment
Group I: PEAL surgeryExperimental Treatment1 Intervention
Patients will undergo percutaneous externally-assembled laparoscopic surgery
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PEAL surgery
2016
N/A
~10

Find a Location

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor
306 Previous Clinical Trials
260,949 Total Patients Enrolled
Mohamed Keheila, MDStudy DirectorLoma Linda University Medical Center
2 Previous Clinical Trials
142 Total Patients Enrolled
~1 spots leftby May 2025